Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Chang

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|October 16, 2012
Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitorsEmily J Hanan, Anne van Abbema, Kathy Barrett, et al.
JAMA Network Open|December 15, 2023
Guiding Principles to Address the Impact of Algorithm Bias on Racial and Ethnic Disparities in Health and Health CareMarshall H Chin, Nasim Afsar-Manesh, Arlene S Bierman, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitorsMichael Siu, Richard Pastor, Wendy Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2013
A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitorsSue J Sohn, Kathy Barrett, Anne Van Abbema, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2012
Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2Sharada Labadie, Peter S Dragovich, Kathy Barrett, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2013
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1Christopher A Hurley, Wade S Blair, Richard J Bull, et al.
Annals of Internal Medicine|September 5, 2018
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationAndrea C Tricco, Erin Lillie, Wasifa Zarin, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2017
Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis modelJun Liang, Anne Van Abbema, Mercedesz Balazs, et al.
Journal of Medicinal Chemistry|May 18, 2012
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitorsJanusz J Kulagowski, Wade Blair, Richard J Bull, et al.
Cochrane Evidence Synthesis and Methods|January 23, 2026
Methods of Engaging Interest-Holders in Healthcare Evidence Syntheses: A Scoping ReviewAlex Todhunter-Brown, Jennifer Petkovic, Christine Chang, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|October 16, 2012
Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitorsEmily J Hanan, Anne van Abbema, Kathy Barrett, et al.
JAMA Network Open|December 15, 2023
Guiding Principles to Address the Impact of Algorithm Bias on Racial and Ethnic Disparities in Health and Health CareMarshall H Chin, Nasim Afsar-Manesh, Arlene S Bierman, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitorsMichael Siu, Richard Pastor, Wendy Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2013
A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitorsSue J Sohn, Kathy Barrett, Anne Van Abbema, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2012
Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2Sharada Labadie, Peter S Dragovich, Kathy Barrett, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2013
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1Christopher A Hurley, Wade S Blair, Richard J Bull, et al.
Annals of Internal Medicine|September 5, 2018
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationAndrea C Tricco, Erin Lillie, Wasifa Zarin, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2017
Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis modelJun Liang, Anne Van Abbema, Mercedesz Balazs, et al.
Journal of Medicinal Chemistry|May 18, 2012
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitorsJanusz J Kulagowski, Wade Blair, Richard J Bull, et al.
Cochrane Evidence Synthesis and Methods|January 23, 2026
Methods of Engaging Interest-Holders in Healthcare Evidence Syntheses: A Scoping ReviewAlex Todhunter-Brown, Jennifer Petkovic, Christine Chang, et al.
Pageof 10